Jump to content

Refractory cytopenia with multilineage dysplasia

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Tom.Reding (talk | contribs) at 00:29, 27 May 2016 (top: CS1 maintenance: vauthors/veditors or enumerate multiple authors/editors; WP:GenFixes on,, added underlinked tag using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Refractory cytopenia with multilineage dysplasia

Refractory cytopenia with multilineage dysplasia is a form of myelodysplastic syndrome.[1]

It is abbreviated "RCMD".[2][3]

References

  1. ^ Rosati S, Mick R, Xu F, et al. (January 1996). "Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome". Leukemia. 10 (1): 20–6. PMID 8558932.
  2. ^ Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D (January 2009). "Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden". Biol. Blood Marrow Transplant. 15 (1): 30–8. doi:10.1016/j.bbmt.2008.10.012. PMID 19135940.
  3. ^ Hamdi W, Ogawara H, Handa H, Tsukamoto N, Nojima Y, Murakami H (November 2008). "Clinical significance of regulatory T cells in patients with myelodysplastic syndrome". Eur. J. Haematol. 82 (3): 201–7. doi:10.1111/j.1600-0609.2008.01182.x. PMID 19018862.